Literature DB >> 29404560

Tissue Markers for Acute Multiple Sclerosis Treatment Response-A Step Toward Personalized Medicine.

Robert J Fox1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29404560     DOI: 10.1001/jamaneurol.2017.4850

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  3 in total

Review 1.  Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis.

Authors:  Patrizia LoPresti
Journal:  Biomedicines       Date:  2022-05-06

2.  Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis.

Authors:  Dumitru Ciolac; Felix Luessi; Gabriel Gonzalez-Escamilla; Nabin Koirala; Christian Riedel; Vinzenz Fleischer; Stefan Bittner; Julia Krämer; Sven G Meuth; Muthuraman Muthuraman; Sergiu Groppa
Journal:  Front Immunol       Date:  2019-07-30       Impact factor: 7.561

Review 3.  Multiple sclerosis: Immunopathological heterogeneity and its implications.

Authors:  Britta Engelhardt; Manuel Comabella; Andrew Chan
Journal:  Eur J Immunol       Date:  2022-05-06       Impact factor: 6.688

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.